Skip to content
Nonprofiteer
← DRUGS FOR NEGLECTED DISEASESINITIATIVE NORTH AMERICA INC

Form 990 for tax year 2024

Filed by DRUGS FOR NEGLECTED DISEASESINITIATIVE NORTH AMERICA INC.

Totals

Total revenue
$6,221,917
Total expenses
$6,349,740
Contributions and grants received
$6,193,831
Grants paid
$3,670,704
Program service revenue
$0
Investment income
$28,086
Other revenue
$0
Total assets, end of year
$2,501,704
Total liabilities, end of year
$1,525,002
Net assets or fund balances, end of year
$976,702
Program services expenses (Part IX)
$5,117,384
Management and general expenses
$642,968
Fundraising expenses
$589,388
Program service expenses (Part III)
$5,117,384

Program services were 80.6% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $6,193,831

  • 3 · Investment income

    total $28,086 · excluded $28,086

Functional expenses

Part IX, the statement of functional expenses.

  • 3 · Grants to foreign organizations and individuals

    total $3,670,704 · program services $3,670,704

  • 5 · Compensation of officers, directors and key employees

    total $592,831 · program services $414,981 · management and general $59,283 · fundraising $118,567

  • 7 · Other salaries and wages

    total $810,473 · program services $365,160 · management and general $257,947 · fundraising $187,366

  • 8 · Pension plan contributions

    total $63,988 · program services $28,075 · management and general $21,026 · fundraising $14,887

  • 9 · Other employee benefits

    total $182,406 · program services $82,621 · management and general $57,671 · fundraising $42,114

  • 10 · Payroll taxes

    total $96,178 · program services $51,936 · management and general $23,083 · fundraising $21,159

  • 11c · Fees: accounting

    total $14,500 · program services $7,830 · management and general $3,480 · fundraising $3,190

  • 13 · Office expenses

    total $702,901 · program services $379,567 · management and general $168,696 · fundraising $154,638

  • 14 · Information technology

    total $6,187 · program services $3,341 · management and general $1,485 · fundraising $1,361

  • 16 · Occupancy

    total $40,000 · program services $21,600 · management and general $9,600 · fundraising $8,800

  • 17 · Travel

    total $135,626 · program services $73,238 · management and general $32,550 · fundraising $29,838

  • 19 · Conferences, conventions and meetings

    total $29,454 · program services $15,905 · management and general $7,069 · fundraising $6,480

  • 23 · Insurance

    total $4,492 · program services $2,426 · management and general $1,078 · fundraising $988

Balance sheet

Part X, book values.

  • 2 · Savings and temporary cash investments

    beginning of year $1,792,054 · end of year $1,770,465

  • 3 · Pledges and grants receivable

    beginning of year $24,041 · end of year $710,755

  • 9 · Prepaid expenses and deferred charges

    beginning of year $3,666 · end of year $20,484

  • 17 · Accounts payable and accrued expenses

    beginning of year $358,039 · end of year $182,413

  • 18 · Grants payable

    beginning of year $357,197 · end of year $1,342,589

  • 27 · Net assets without donor restrictions

    beginning of year $934,525 · end of year $964,225

  • 28 · Net assets with donor restrictions

    beginning of year $170,000 · end of year $12,477

Mission and programs · 2024

Mission

THE MISSION OF DNDI NORTH AMERICA IS TO CONTRIBUTE TO THE ACHIEVEMENT OF DNDI'S GLOBAL OBJECTIVES, IN PARTICULAR TO STRENGHTEN AND EXPAND DNDI'S SCIENTIFIC, POLICY ADVOCACY, FUNDRAISING, AND COMMUNICATIONS EFFORTS IN NORTH AMERICA BY (A) PROVIDING FOCUSED SUPPORT FOR SPECIFIC R&D PROJECTS AND BUSINESS/PARTNER DEVELOPMENT ACTIVITIES IN NORTH AMERICA;(B) ACHIEVING CONCRETE POLICY CHANGES IN NORTH AMERICA TO CREATE A MORE FAVORABLE ENVIRONMENT FOR NEEDS-DRIVEN R&D FOR NEGLECTED DISEASES;(C) MOBILIZING PUBLIC AND PRIVATE FUNDS IN NORTH AMERICA TO SUPPORT DNDI'S MISSION;(D) INCREASING DNDI'S PROFILE AND VISIBILITY IN NORTH AMERICA, THEREBY DRAWING GREATER PUBLIC ATTENTION TO THE NEED FOR NEGLECTED DISEASE R&D.

Activities or mission (Part I)

THE DRUGS FOR NEGLECTED DISEASES INITIATIVE (DNDI), NORTH AMERICA SUPPORTS DNDI'S GLOBAL VISION AND MISSION TO DEVELOP NEW DRUGS, OR NEW FORMULATIONS OF EXISTING DRUGS FOR PATIENTS SUFFERING FROM THE MOST NEGLECTED DISEASES. ACTING IN THE PUBLIC INTEREST, DNDI BRIDGES EXISTING R&D GAPS IN ESSENTIAL DRUGS FOR THESE DISEASES BY INITIATING AND COORDINATING DRUG R&D PROJECTS IN COLLABORATION WITH THE INTERNATIONAL RESEARCH COMMUNITY, THE PUBLIC SECTOR, THE PHARMACEUTICAL INDUSTRY, AND OTHER PARTNERS.

  • GRANTS TO RESEARCH AND DEVELOPMENT FOR NEGLECTED DISEASES: DNDI NORTH AMERICA RAISES FUNDS TO SUPPORT DNDI'S RESEARCH AND DEVELOPMENT (R&D) ACTIVITIES IN ORDER TO CONTRIBUTE TO THE ACHIEVEMENT OF DNDI'S GOAL OF DELIVERING 25 NEW TREATMENTS FOR NEGLECTED PATIENTS BY 2028 AND ESTABLISHING A ROBUST PIPELINE OF NEW POTENTIAL DRUG CANDIDATES. DNDI NOW HAS OVER 30 PROJECTS IN ITS PIPELINE, INCLUDING OVER 20 POTENTIAL NEW CHEMICAL ENTITIES (NCES), AND HAS DELIVERED 12 TREATMENTS OFR SIX DEADLY DISEASES THAT ARE ALREADY IN THE HANDS OF MILLIONS OF PATIENTS.

    Expenses $5,117,384 · Grants $3,670,704

  • RAISING PUBLIC AWARENESS AND ADVOCATING FOR NEGLECTED DISEASE R&D:AS PART OF ITS MISSION, DNDI ADVOCATES FOR ENHANCED POLITICAL LEADERSHIP, INCREASED RESOURCES, AND AN ENABLING POLICY ENVIRONMENT TO STIMULATE R&D FOR NEGLECTED DISEASES. DNDI NORTH AMERICA ACTIVELY ADVOCATES FOR SOUND POLICIES, PARTICULARLY IN THE UNITED STATES, THAT WILL ENABLE GREATER NEEDS-DRIVEN R&D, INCLUDING APPROPRIATE INCENTIVES AND FINANCING MECHANISMS, INNOVATIVE REGULATORY PATHWAYS THAT EXPEDITE ACCESS, AND OPEN INNOVATION APPROACHES TO INTELLECTUAL PROPERTY MANAGEMENT THAT ENSURE THE WIDEST POSSIBLE SHARING OF RESEARCH KNOWLEDGE AND DATA.

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • LUIS PIZARRO

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    2

  • MEENA AHAMED

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    2

  • AFRICA STEWART

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    2

  • BENNETT SHAPIRO

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    2

  • KRISTINA TORGESON

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    2

  • DARIN PORTNOY

    CHAIR OF THE BOARD

    Total calculated
    $0
    Hours/week
    3

  • SHING CHANG

    SECRETARY

    Total calculated
    $0
    Hours/week
    2

  • JOHN LAWRENCE

    TREASURER

    Total calculated
    $0
    Hours/week
    2

  • DELALI ATTIPOE

    EXECUTIVE DIRECTOR

    Total calculated
    $310,984
    From this org
    $239,914
    From related orgs
    $0
    Other
    $71,070
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $239,914
    Bonus
    $0
    Other
    $0
    Deferred
    $21,450
    Nontaxable benefits
    $49,620
    Filer's total
    $310,984

  • RACHEL COHEN

    SENIOR ADVISOR, GLOBAL POL

    Total calculated
    $281,847
    From this org
    $213,183
    From related orgs
    $0
    Other
    $68,664
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $213,183
    Bonus
    $0
    Other
    $0
    Deferred
    $19,044
    Nontaxable benefits
    $49,620
    Filer's total
    $281,847

  • ILAN MOSS

    HEAD OF MEDIA AND CONTENT

    Total calculated
    $170,416
    From this org
    $156,476
    From related orgs
    $0
    Other
    $13,940
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $156,476
    Bonus
    $0
    Other
    $0
    Deferred
    $13,940
    Nontaxable benefits
    $0
    Filer's total
    $170,416

  • VISHAL GOYAL

    SENIOR CLINICAL PROJECT AN

    Total calculated
    $177,424
    From this org
    $146,409
    From related orgs
    $0
    Other
    $31,015
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $146,409
    Bonus
    $0
    Other
    $0
    Deferred
    $8,201
    Nontaxable benefits
    $22,814
    Filer's total
    $177,424

  • SHIRLEY LEUNG

    SENIOR HR BUSINESS PARTNER

    Total calculated
    $150,994
    From this org
    $106,712
    From related orgs
    $0
    Other
    $44,282
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $106,712
    Bonus
    $0
    Other
    $0
    Deferred
    $9,461
    Nontaxable benefits
    $34,821
    Filer's total
    $150,994

  • RON SYKES

    SENIOR INDIVIDUAL GIVING MANAGER

    Total calculated
    $151,647
    From this org
    $123,284
    From related orgs
    $0
    Other
    $28,363
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $123,284
    Bonus
    $0
    Other
    $0
    Deferred
    $10,953
    Nontaxable benefits
    $17,410
    Filer's total
    $151,647

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Form 990 of other organizations
  • 3 · Written employment contract
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

No itemized grants to organizations on this return.

Provenance

Return type
form_990
Tax year
2024
Filed
17 November 2025
IRS schema version
2024v5.2
Source object
202503219349317475

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.